It appears you don't have support to open PDFs in this web browser. To view this file, Open with your PDF reader
Abstract
To evaluate if Indigenous Australians have higher coronary inflammation demonstrated non-invasively using pericoronary adipose tissue attenuation on coronary computed tomography angiography (CCTA). We retrospectively obtained a cohort 54 Indigenous patients age- and sex-matched to 54 non-Indigenous controls (age: 46.5 ± 13.1 years; male: n = 66) undergoing CCTA at the Royal Darwin Hospital and Monash Medical Centre. Patient groups were defined to investigate the interaction of ethnicity and sex: Indigenous + male, Indigenous + female, control + male, control + female. Semi-automated software was used to assess pericoronary adipose tissue attenuation (PCAT-a) and volume (PCAT-v). Males had significantly higher PCAT-a (– 86.7 ± 7.8 HU vs. − 91.3 ± 7.1 HU, p = 0.003) than females. Indigenous patients had significantly higher PCAT-v (1.5 ± 0.5cm3 vs. 1.3 ± 0.4cm3, p = 0.032), but only numerically higher PCAT-a (p = 0.133) than controls. There was a significant difference in PCAT-a and PCAT-v across groups defined by Indigenous status and sex (p = 0.010 and p = 0.030, respectively). Among patients with matching CCTA contrast density, multivariable linear regression analysis showed an independent association between Indigenous status and PCAT-a. Indigenous men have increased PCAT-a in an age- and sex-matched cohort. Male sex is strongly associated with increased PCAT-a. Coronary inflammation may contribute to adverse cardiovascular outcomes in Indigenous Australians, but larger studies are required to validate these findings.
You have requested "on-the-fly" machine translation of selected content from our databases. This functionality is provided solely for your convenience and is in no way intended to replace human translation. Show full disclaimer
Neither ProQuest nor its licensors make any representations or warranties with respect to the translations. The translations are automatically generated "AS IS" and "AS AVAILABLE" and are not retained in our systems. PROQUEST AND ITS LICENSORS SPECIFICALLY DISCLAIM ANY AND ALL EXPRESS OR IMPLIED WARRANTIES, INCLUDING WITHOUT LIMITATION, ANY WARRANTIES FOR AVAILABILITY, ACCURACY, TIMELINESS, COMPLETENESS, NON-INFRINGMENT, MERCHANTABILITY OR FITNESS FOR A PARTICULAR PURPOSE. Your use of the translations is subject to all use restrictions contained in your Electronic Products License Agreement and by using the translation functionality you agree to forgo any and all claims against ProQuest or its licensors for your use of the translation functionality and any output derived there from. Hide full disclaimer
Details
1 Victorian Heart Institute, MonashHeart and Monash University, Monash Health, Monash Cardiovascular Research Centre, Clayton, Australia (GRID:grid.419789.a) (ISNI:0000 0000 9295 3933); Monash University, School of Clinical Sciences, Clayton, Australia (GRID:grid.1002.3) (ISNI:0000 0004 1936 7857)
2 Victorian Heart Institute, MonashHeart and Monash University, Monash Health, Monash Cardiovascular Research Centre, Clayton, Australia (GRID:grid.419789.a) (ISNI:0000 0000 9295 3933)
3 Royal Darwin Hospital, Division of Medicine, Tiwi, Australia (GRID:grid.240634.7) (ISNI:0000 0000 8966 2764); Gold Coast University Hospital, Department of Cardiology, Southport, Australia (GRID:grid.413154.6) (ISNI:0000 0004 0625 9072)
4 Royal Darwin Hospital, Division of Medicine, Tiwi, Australia (GRID:grid.240634.7) (ISNI:0000 0000 8966 2764)
5 Biomedical Imaging Research Institute, Cedars-Sinai Medical Center, Los Angeles, USA (GRID:grid.50956.3f) (ISNI:0000 0001 2152 9905)